pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects.
Albuquerque LJC, Sincari V, Jäger A, Kucka J, Humajova J, Pankrac J, Paral P, Heizer T, Janouškova O, Davidovich I, Talmon Y, Pouckova P, Štěpánek P, Sefc L, Hruby M, Giacomelli FC, Jäger E.
Albuquerque LJC, et al. Among authors: talmon y.
J Control Release. 2021 Apr 10;332:529-538. doi: 10.1016/j.jconrel.2021.03.013. Epub 2021 Mar 12.
J Control Release. 2021.
PMID: 33716094